Completed EARLY_PHASE1 INTERVENTIONAL 1-arm NCT02240329

Assessment of Dystussia in Traumatic Brain Injury

Sponsor: United States Department of Defense

Interventions Capsaicin cough sensitivity testing Neuropsychological Testing and Measures of TBI severity Respiratory measures

Updated 8 times since 2017 Last updated: Sep 29, 2015 Started: Mar 31, 2013 Primary completion: Jun 30, 2015 Completion: Jun 30, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A EARLY_PHASE1 clinical study on Brain Injury and TBI, this trial is completed. The trial is conducted by United States Department of Defense and has accumulated 8 data snapshots since 2013. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed EARLY_PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed EARLY_PHASE1
Jan 2023 — Jul 2024 [monthly]

Completed EARLY_PHASE1
Dec 2022 — Jan 2023 [monthly]

Completed EARLY_PHASE1
Jan 2021 — Dec 2022 [monthly]

Completed EARLY_PHASE1

▶ Show 3 earlier versions

Jun 2018 — Jan 2021 [monthly]

Completed EARLY_PHASE1
Feb 2017 — Jun 2018 [monthly]

Completed EARLY_PHASE1

Phase: Phase 0 → EARLY_PHASE1
Jan 2017 — Feb 2017 [monthly]

Completed Phase 0

First recorded

Mar 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

United States Department of Defense
University of Florida

Data source: University of Florida

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Gainesville, United States